Micieli G, De Falco FA, Consoli D, Inzitari D, Sterzi R, Tedeschi G, Toni D. The role of emergency neurology in Italy: outcome of a consensus meeting for a intersociety position. Neurol Sci 2012; 33(2):297-304

Calabrò RS, Gervasi G, Bramanti P, Cavallini A. Thrombolysis in Ischemic Stroke: Focus on New Treatment Strategies. Recent Pat Cardiovasc Drug Discov 2012; 7(1):42-52

 Bersano A, Lanfranconi S, Valcarenghi C, Bresolin N, Micieli G, Baron P. Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy. Acta Neurol Scand 2012; 126(2):77-97

 Greco R, Amantea D, Mangione AS, Petrelli F, Gentile R, Nappi G, Blandini F, Corasaniti MT, Tassorelli C. Modulation of RAGE Isoforms Expression in the Brain and Plasma of Rats Exposed to Transient Focal Cerebral Ischemia. Neurochem Res 2012; 37(7):1508-16

 Bersano A, Debette S, Zanier ER, Lanfranconi S, De Simoni MG, Zuffardi O, Micieli G. The Genetics of Small-Vessel Disease. Curr Med Chem 2012; 19(24):4124-41

Bersano A, Baron P, Lanfranconi S, Trobia N, Sterzi R, Motto C, Comi G, Sessa M, Martinelli-Boneschi F, Micieli G, Ferrarese C, Santoro P, Parati E, Boncoraglio G, Padovani A, Pezzini A, Candelise L, Candelise L. Lombardia GENS: a collaborative registry for monogenic diseases associated with stroke. Funct Neurol 2012 ; 27(2):107-17

Canova D, Roatta S, Micieli G, Bosone D. Cerebral oxygenation and haemodynamic effectsinduced by nimodipine in healthy subjects.Funct Neurol 2012 ;27(3):169-76

 Cortese A, Baldanti F, Tavazzi E, Carnevale L, Minoli L, Lozza A, Marchioni E. Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic i+A10:C33nfluenza A (H1N1) virus: Case report and review of the literature. J Neurol Sci 2012; 312 : 173–6

Tavazzi E, White MK, Khalili K. Progressive multifocal leukoencephalopathy: clinical and molecular aspects. Rev Med Virol 2012; 22(1):18-32

Montomoli C, Citterio A, Piccolo G, Cioccale R, Ferretti V, Fratti C, Bergamaschi R, Cosi VE. Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy. Neuroepidemiology 2012; 38(2):100-5

Hughes S, Spelman T, Trojano M, Lugaresi A, Izquierdo G, Grand’maison F, Duquette P, Girard M, Grammond P, Oreja-Guevara C, Hupperts R, Boz C, Bergamaschi R, Giuliani G, Rio ME, Lechner-Scott J, van Pesch V, Iuliano G, Fiol M, Verheul F, Barnett M, Slee M, Herbert J, Kister I, Vella N, Moore F, Petkovska-Boskova T, Shaygannejad V, Jokubaitis V, McDonnell G, Hawkins S, Kee F, Gray O, Butzkueven H. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. J Neurol Neurosurg Psychiatry 2012; 83(3):305-10

Pichiecchio A, Tavazzi E, Poloni G, Ponzio M, Palesi F, Pasin M, Piccolo L, Tosello D, Romani A, Bergamaschi R, Piccolo G, Bastianello S. Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler J 2012; 18(6):817-24

 Meyniel C, Spelman T, Jokubaitis VG, Trojano M, Izquierdo G, Grand’maison F, Oreja-Guevara C, Boz C, Lugaresi A, Girard M, Grammond P, Iuliano G, Fiol M, Cabrera-Gomez JA, Fernandez-Bolanos R, Giuliani G, Lechner-Scott J, Cristiano E, Herbert J, Petkovska-Boskova T, Bergamaschi R, van Pesch V, Moore F, Vella N, Slee M, Santiago V, Barnett M, Havrdova E, Young C, Sirbu CA, Tanner M, Rutherford M, Butzkueven H. Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. PLoS One 2012; 7(6): e38661

 Delbue S, Elia F, Carloni C, Tavazzi E, Marchioni E, Carluccio S, Signorini L, Novati S, Maserati R, Ferrante P. JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy. J Cell Physiol 2012; 227(10):3511-7

 Kister I, Chamot E, Cutter G, Bacon TE, Jokubaitis VG, Hughes SE, Gray OM, Trojano M, Izquierdo G, Grand’maison F, Duquette P, Lugaresi A, Grammond P, Boz C, Hupperts R, Petersen T, Giuliani G, Oreja-Guevara C, Iuliano G, Lechner-Scott J, Bergamaschi R, Rio ME, Verheul F, Fiol M, Van Pesch V, Slee M, Butzkueven H, Herbert J. Increasing age at disability milestones among MS patients in the MSBase Registry. J Neurol Sci 2012; 318(1-2):94-9

Menni C, Lowell WE, Bentzen J, Bergamaschi R, Martinelli Boneschi F, Martinelli V, Bernardinelli L, Stenager E, Davis GE, Foco L.Short and long term variation in ultraviolet radiation and multiple sclerosis. Int J Environ Res Public Health 2012; 9(3): 685-97

 Lechner-Scott J, Spencer B, de Malmanche T, Attia J, Fitzgerald M, Trojano M, Grand’maison F, Antonio C Gomez J, Izquierdo G, Duquette P, Girard M, Grammond P, Oreja-Guevara C, Hupperts R, Bergamaschi R, Boz C, Giuliani G, Pesch VV, Iuliano G, Fiol M, Cristiano E, Verheul F, Saladino ML, Slee M, Barnett M, Deri N, Fletcher S, Vella N, Shaw C, Herbert J, Moore F, Petkovska-Boskova T, Jokubatis V, Butzkueven H. The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Mult Scler 2012; 18(7):974-982

 Jarius S, Franciotta D, Paul F, Bergamaschi R, Rommer PS, Ruprecht K, Ringelstein M, Aktas O, Kristoferitsch W, Wildemann B.Testing for antibodies to human aquaporin-4 by ELISA: Sensitivity, specificity, and direct comparison with immunohistochemistry. J Neurol Sci 2012; 320(1-2):32-7

 Jarius S, Paul F, Franciotta D, de Seze J, Münch C, Salvetti M, Ruprecht K, Liebetrau M, Wandinger K, Akman-Demir G, Melms A, Kristoferitsch W, Wildemann B. Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler J 2012; 18(8):1135-43

 Mallucci G, Franciotta D, Romani A, Ceroni M, Bergamaschi R. Anti-aquaporin-4 antibody-positive recurrent isolated optic neuritis and primary Sjögren’s syndrome.J Neurol 2012; 259(8):1740-1

 Di Filippo M, Franciotta D, Massa R, Di Gregorio M, Zardini E, Gastaldi M, Terracciano C, Rastelli E, Gaetani L, Iannone A, Menduno P, Floridi P, Sarchielli P, Calabresi P. Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica.Neurology 2012 ; 79(11): 1182-4

Pisani V, Stefani A, Pierantozzi M, Natoli S, Stanzione P, Franciotta D, Pisani A. Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease. J Neuroinflammation 2012; 9(–): 188

 Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Picconi O, Cilia S, Cottone S, Grimaldi LM. Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon -1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II). Qual Life Res 202 ; 21(7):1111-21

Zanin V, Delbue S, Marcuzzi A, Tavazzi E, Del Savio R, Crovella S, Marchioni E, Ferrante P, Comar M. Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. J Neurovirol 2012; 18 (5): 416-22

Goretti B, Portaccio E, Ghezzi A, Lori S, Moiola L, Falautano M, Viterbo R, Patti F, Vecchio R, Pozzilli C, Bianchi V, Cappiello S, Comi G, Trojano M, Amato MP (in which Bergamaschi R, Veggiotti P). Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis. Mult Scler 2012; 18(3):329-34

 Grecchi S, Mazzini G, Lisa A, Armentero MT, Bergamaschi R, Romani A, Blandini F, Di Perri C, Scovassi AI. Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study. PLoS One 2012; 7(9): e44935

Ferrò MT, Franciotta D, Prelle A, Bestetti A, Cinque P. Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis. J Neurovirol 2012; 18(5):437-40

 Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson S, Lepore V, Grand’maison F, Duquette P, Izquierdo G, Grammond P, Amato MP, Bergamaschi R, Giuliani G, Boz C, Hupperts R, Van Pesch V, Lechner-Scott J, Cristiano E, Fiol M, Oreja-Guevara C, Saladino ML, Verheul F, Slee M, Paolicelli D, Tortorella C, D’Onghia M, Iaffaldano P, Direnzo V, Butzkueven H. Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis. PLoS One ,2012;7(10):e48078

Vairetti M, Ferrigno A, Rizzo V, Ambrosi G, Bianchi A, Richelmi P, Blandini F, Armentero MT. Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson’s disease: A self-perpetuating crosstalk? Biochim Biophys Acta 2012; 1822(2):176-84

Melcangi RC, Caruso D, Levandis G, Abbiati F, Armentero MT, Blandini F. Modifications of Neuroactive Steroid Levels in an Experimental Model of Nigrostriatal Degeneration: Potential Relevance to the Pathophysiology of Parkinson’s Disease. J Mol Neurosci 2012; 46(1):177-83

Tiloca C, Ratti A, Pensato V, Castucci A, Sorarù G, Del Bo R, Corrado L, Cereda C, D’Ascenzo C, Comi GP, Mazzini L, Castellotti B, Ticozzi N, Gellera C, Silani V, Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis. Neurobiol Aging 2012; 33(3):630.e1-2

Tassorelli C, Furnari A, Buscone S, Alfonsi E, Pacchetti C, Zangaglia R, Pichiecchio A, Bastianello S, Lozza A, Allena M, Bolla M, Sandrini G, Nappi G, Martignoni E. Pisa syndrome in Parkinson’s disease: Clinical, electromyographic, and radiological characterization. Mov Disord 2012; 27(2):227-35

 Milani P, Gagliardi S, Bongioanni P, Grieco GS, Dezza M, Bianchi M, Cova E, Ceroni M, Cereda C. Effect of the 50bp deletion polymorphism in the SOD1 promoter on SOD1 mRNA levels in Italian ALS patients. J Neurol Sci 2012; 313(1-2):75-8

Cova L, Bossolasco P, Armentero MT, Diana V, Zennaro E, Mellone M, Calzarossa C, Cerri S, Lambertenghi Deliliers G, Polli E, Blandini F, Silani V. Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson’s disease. Apoptosis 2012; 17(3):289-304

 Blandini F, Armentero MT. New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson’s disease: targeting glutamate and adenosine receptors. Expert Opin Investig Drugs 2012; 21(2):153-68

 Bossolasco P, Cova L, Levandis G, Diana V, Cerri S, Lambertenghi Deliliers G, Polli E, Silani V, Blandini F, Armentero MT. Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson’s disease. Int J Nanomedicine 2012; 7: 435 – 47

 Blandini F, Armentero MT. Animal models of Parkinson’s disease. FEBS J 2012; 279(7):1156-66

 Zucchella C, Bartolo M, Pasotti C, Chiapella L, Sinforiani E. Caregiver Burden and Coping in Early-stage Alzheimer Disease. Alzheimer Dis Assoc Disord 2012; 26(1): 55-60

 Gagliardi S, Ghirmai S, Abel KJ, Lanier M, Gardai SJ, Lee C, Cashman JR. Evaluation in vitro of synthetic curcumins as agents promoting monocytic gene expression related to -amyloid clearance. Chem Res Toxicol 2012; 25(1):101-12

 Guareschi S, Cova E, Cereda C, Ceroni M, Donetti E, Bosco DA, Trotti D, Pasinelli P. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc Natl Acad Sci U S A 2012; 109(13):5074-9

 Cashman JR, Gagliardi S, Lanier M, Ghirmai S, Abel KJ, Fiala M. Curcumins Promote Monocytic Gene Expression Related to -Amyloid and Superoxide Dismutase Clearance. Neurodegener Dis 2012; 10(1-4):274-6

 Gagliardi S, Davin A, Ricca I, Grieco GS, Zangaglia R, Pierelli F, Ghiroldi A, Pacchetti C, Casali C, Cereda C. A new GLUT-1 mutation in a family with glucose transporter 1 deficiency syndrome. Mov Disord 2012; 27(6):804-5

 Palesi F, Vitali P, Chiarati P, Castellazzi G, Caverzasi E, Pichiecchio A, Colli-Tibaldi E, D’Amore F, D’Errico I, Sinforiani E, Bastianello S. DTI and MR Volumetry of Hippocampus-PC/PCC Circuit: In Search of Early Micro- and Macrostructural Signs of Alzheimers’s Disease. Neurol Res Int 2012; 2012(–): 517876

 Morelli M, Blandini F, Simola N, Hauser RA. A(2A) Receptor Antagonism and Dyskinesia in Parkinson’s Disease. Parkinsons Dis 2012; 2012(–):489853

 Gagliardi S, Milani P, Sardone V, Pansarasa O, Cereda C. From Transcriptome to Noncoding RNAs: Implications in ALS Mechanism. Neurol Res Int 2012; 2012(–):278725

 Colucci M, Cervio M, Faniglione M, De Angelis S, Pajoro M, Levandis G, Tassorelli C, Blandini F, Feletti F, De Giorgio R, Dellabianca A, Tonini S, Tonini M . Intestinal dysmotility and enteric neurochemical changes in a Parkinson’s disease rat model. Auton Neurosci 2012; 169(2):77-86

 Pisani V, Stefani A, Pierantozzi M, Natoli S, Stanzione P, Franciotta D, Pisani A. Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease. J Neuroinflammation 2012; 9(1):188

 Ratti A, Corrado L, Castellotti B, Del Bo R, Fogh I, Cereda C, Tiloca C, D’Ascenzo C, Bagarotti A, Pensato V, Ranieri M, Gagliardi S, Calini D, Mazzini L, Taroni F, Corti S, Ceroni M, Oggioni GD, Lin K, Powell JF, Sorarù G, Ticozzi N, Comi GP, D’Alfonso S, Gellera C, Silani V.C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 2012; 33(10):2528.e7-2528.e14

 Giannicola G, Rosa M, Servello D, Menghetti C, Carrabba G, Pacchetti C, Zangaglia R, Cogiamanian F, Scelzo E, Marceglia S, Rossi L, Priori A. Subthalamic Local Field Potentials After Seven-Years Deep Brain Stimulation in Parkinson’s Disease. Exp Neurol 2012; 237(2):312-317

 Mauri M, Sinforiani E, Zucchella C, Cuzzoni MG, Bono G. Progression to dementia in a population with amnestic mild cognitive impairment: clinical variables associated with conversion. Funct Neurol 2012; 27(1):49-54

 Zangaglia R, Pasotti C, Mancini F, Servello D, Sinforiani E, Pacchetti C. Deep brain stimulation and cognition in Parkinson’s disease: An eight-year follow-up study. Mov Disord 2012; 27(9):1192-4

 Tinazzi M, Cipriani A, Matinella A, Cannas A, Solla P, Nicoletti A, Zappia M, Morgante L, Morgante F, Pacchetti C, Sciarretta M, Dallocchio C, Rossi S, Malentacchi M, Ceravolo R, Frosini D, Sestini S, Bovi T, Barbui C. FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. Schizophr Res 2012; 139(1-3):40-5

 Sinforiani E, Pasotti C, Chiapella L, Malinverni P, Zucchella C. Memantine in Alzheimer’s disease: experience in an Alzheimer’s disease assessment unit. Aging Clin Exp Res 2012; 24(2):193-6

 Ferrari M, Martignoni E, Blandini F, Riboldazzi G, Bono G, Marino F, Cosentino M. Association of UDP-glucuronosyl transferase 1A9 polymorphisms with adverse reactions to catechol-O-methyltransferase inhibitors in Parkinson’s disease patients. Eur J Clin Pharmacol 2012; 68 (11): 1493-9

 Sinforiani E, Pasotti C, Chiapella L, Picascia M, Zucchella C. Clinical characteristics of population referred to an Italian center for dementia. Aging Clin Exp Res. 2012; 24:104-5

 Zucchella C, Sinforiani E, Citterio A, Giarracca V, Bono G, Mauri M. Reproductive life events and Alzheimer’s disease in Italian women: a retrospective study. Neuropsychiatr Dis Treat 2012; 8(–):555-60

 Nisticò R, Cavallucci V, Piccinin S, Macrì S, Pignatelli M, Mehdawy B, Blandini F, Laviola G, Lauro D, Mercuri NB, D’Amelio M . Insulin Receptor -Subunit Haploinsufficiency Impairs Hippocampal Late-Phase LTP and Recognition Memory. Neuromolecular Med 2012; 14(4):262-9

 Lanni C, Garbin G, Lisa A, Biundo F, Ranzenigo A, Sinforiani E, Cuzzoni G, Govoni S, Ranzani GN, Racchi M. Influence of COMT Val158Met Polymorphism on Alzheimer’s Disease and Mild Cognitive Impairment in Italian Patients. J Alzheimers Dis 2012; 32(4):919-26

 Stanga S, Lanni C, Sinforiani E, Mazzini G, Racchi M. Searching for Predictive Blood Biomarkers: Misfolded p53 in Mild Cognitive Impairment. Curr Alzheimer Res 2012; 9(10):1191-7

 Cosentino M, Blandini F, Armentero MT, Martignoni ES, Nappi G, Lecchini S, Marino F. The neurotoxins rotenone, paraquat and manganese exert different effects on human isolated Lymphocites. J Pharmaceutical Sciences and Research 2012; Vol.4(2): 1697-702

 Sassi M, Zekaj E, Grotta A, Pollini A, Pellanda A, Borroni M, Pacchetti C, Menghetti C, Porta M, Servello D. Safety in the Use of Dexmedetomidine (Precedex) for Deep Brain Stimulation Surgery: Our Experience in 23 Randomized Patients. Neuromodulation 2012

 Chiappedi M, Maffioletti E, Piazza F, D’Adda N, Tamburini M, Balottin U. Abilities of preschoolers: comparing different tools. Ital J Pediatr 2012; 38(1):3

 Izzotti A, Longobardi M, Cartiglia C, Anzuini F, Arrigo P, Fazzi E, Orcesi S, La Piana R, Pulliero A. Different Mutations in Three Prime Repair Exonuclease 1 and Ribonuclease H2 Genes Affect Clinical Features in Aicardi-Goutieres Syndrome. J Child Neurol 2012; 27(1):51-60

 Fusar-Poli P, Hobson R, Raduelli M, Balottin U. Reliability and Validity of the Comprehensive Assessment of the at Risk Mental State, Italian Version (CAARMS-I). Curr Pharm Des 2012; 18(4):386-91

 Olivieri I, Bova SM, Urgesi C, Ariaudo G, Perotto E, Fazzi E, Stronati M, Fabbro F, Balottin U, Orcesi S. Outcome of extremely low birth weight infants: What’s new in the third millennium? Neuropsychological profiles at four years. Early Hum Dev 2012; 88(4):241-50

 Tagliabue A, Bertoli S, Trentani C, Borrelli P, Veggiotti P. Effects of the ketogenic diet on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically refractory epilepsy: A 6-month prospective observational study. Clin Nutr 2012; 31(2):246-9

 Fusar-Poli P, Rubia K, Rossi G, Sartori G, Balottin U. Striatal Dopamine Transporter Alterations in ADHD: Pathophysiology or Adaptation to Psychostimulants? A Meta-Analysis. Am J Psychiatry 2012; 169(3):264-72

Pulliero A, Marengo B, Domenicotti C, Longobardi MG, Fazzi E, Orcesi S, Bianchi M, Balottin U, Izzotti A. Inhibition of neuroblastoma cell growth by TREX1-mutated human lymphocytes. Oncol Rep 2012; 27(5):1689-94

 Balottin U, Calcaterra E, Zambonin F, Veggiotti P, Luoni C, Termine C. Chorea mollis: long-term follow-up of an infantile case. Neurol Sci 2012; 33(3):643-5

 Fazzi E, Signorini SG, LA Piana R, Bertone C, Misefari W, Galli J, Balottin U, Bianchi PE. Neuro-ophthalmological disorders in cerebral palsy: ophthalmological, oculomotor, and visual aspects. Dev Med Child Neurol 2012; 54(8):730-6

 Bello L, Piva L, Barp A, Taglia A, Picillo E, Vasco G, Pane M, Previtali SC, Torrente Y, Gazzerro E, Motta MC, Grieco GS, Napolitano S, Magri F, D’Amico A, Astrea G, Messina S, Sframeli M, Vita GL, Boffi P, Mongini T, Ferlini A, Gualandi F, Soraru’ G, Ermani M, Vita G, Battini R, Bertini E, Comi GP, Berardinelli A, Minetti C, Bruno C, Mercuri E, Politano L, Angelini C, Hoffman EP, Pegoraro E. Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. Neurology 2012; 79(2):159-62

 Signorini SG, Decio A, Fedeli C, Luparia A, Antonini M, Bertone C, Misefari W, Ruberto G, Bianchi PE, Balottin U. Septo-optic dysplasia in childhood: the neurological, cognitive and neuro-ophthalmological perspective. Dev Med Child Neurol 2012; 54(11):1018-24

 Orcesi S, Olivieri I, Longo S, Perotti G, La Piana R, Tinelli C, Spinillo A, Balottin U, Stronati M. Neurodevelopmental outcome of preterm very low birth weight infants born from 2005 to 2007. Eur J Paediatr Neurol 2012; 16(6):716-23

 Tonduti D, Pichiecchio A, La Piana R, Livingston JH, Doherty DA, Majumdar A, Tomkins S, Mine M, Ceroni M, Ricca I, Balottin U, Orcesi S. COL4A1-Related Disease: Raised Creatine Kinase and Cerebral Calcification as Useful Pointers. Neuropediatrics 2012; 43(5):283-8

 Chiappedi M, Togni R, De Bernardi E, Baschenis IM, Battezzato S, Balottin U, Toffola ED, Bejor M. rm trajectories and writing strategy in healthy children. BMC Pediatr 2012; 12(1):173

 Cavanna AE, Selvini C, Termine C, Balottin U, Eddy CM. Tolerability profile of clonidine in the treatment of adults with tourette syndrome. Clin Neuropharmacol 2012; 35(6):269-72

 Schmidt JL, Olivieri I, Vento JM, Fazzi E, Gordish-Dressman H, Orcesi S, Vanderver A. Family history of autoimmune disease in patients with aicardi-goutières syndrome. Clin Dev Immunol 2012; 2012(–):206730

 Muratori F, Tancredi R, Massagli A, Esposito D, Villa L, Valli A, Molteni M, Militerni R, Frolli A, Balottin U, Carigi T, Gallo ML, Giuberti V, Pitanti V, Germelli C, Giorgi A, Vannucchi L, Armellini M, Campanile S, Casella C, Monti A, Masini S, Pini G, Calugi S, A. Narzisi A. Effetti a sei mesi dell’intervento precoce nei disturbi dello spettro autistico. Gior Neuropsich Età Evol 2012; 32:135-50

 Pane M, Lombardo ME, Alfieri P, D’Amico A, Bianco F, Vasco G, Piccini G, Mallardi M, Romeo DM, Ricotti V, Ferlini A, Gualandi F, Vicari S, Bertini E, Berardinelli A, Mercuri E. Attention Deficit Hyperactivity Disorder and Cognitive Function in Duchenne Muscular Dystrophy: Phenotype-Genotype Correlation. J Pediatr 2012; 22(8):685-9

 Pane M, Messina S, Vasco G, Foley AR, Morandi L, Pegoraro E, Mongini T, D’Amico A, Bianco F, Lombardo ME, Scalise R, Bruno C, Berardinelli A, Pini A, Moroni I, Mora M, Toscano A, Moggio M, Comi G, Santorelli FM, Bertini E, Muntoni F, Mercuri E. Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency. Neuromuscul Disord 2012; 22(8):685-9

 Estrada-Cuzcano A, Koenekoop RK, Senechal A, De Baere EB, de Ravel T, Banfi S, Kohl S, Ayuso C, Sharon D, Hoyng CB, Hamel CP, Leroy BP, Ziviello C, Lopez I, Bazinet A, Wissinger B, Sliesoraityte I, Avila-Fernandez A, Littink KW, Vingolo EM, Signorini S, Banin E, Mizrahi-Meissonnier L, Zrenner E, Kellner U, Collin RW, den Hollander AI, Cremers FP, Klevering BJ. BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome. Arch Ophthalmol 2012;130(11): 1425-32

 Scionti I, Greco F, Ricci G, Govi M, Arashiro P, Vercelli L, Berardinelli A, Angelini C, Antonini G, Cao M, Di Muzio A, Moggio M, Morandi L, Ricci E, Rodolico C, Ruggiero L, Santoro L, Siciliano G, Tomelleri G, Trevisan CP, Galluzzi G, Wright W, Zatz M, Tupler R. Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet 2012; 90(4): 628-35

Terrazzino S, Tassorelli C, Sances G, Allena M, Viana M, Monaco F, Bellomo G, Nappi G, Canonico PL, Genazzani AA. Association of haplotype combination of serotonin transporter gene polymorphisms with monthly headache days in MOH patients. Eur J Neurol 2012; 19(1): 69-75

 Berliocchi L, Russo R, Tassorelli C, Morrone LA, Bagetta G, Corasaniti MT. Death in pain: peripheral nerve injury and spinal neurodegenerative mechanisms. Curr Opin Pharmacol 2012; 12(1):49-54

 Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andrée C. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 2012; 19(5):703-711

Nappi RE, Terreno E, Tassorelli C, Sances G, Allena M, Guaschino E, Antonaci F, Albani F, Polatti F . Sexual Function and Distress in Women Treated for Primary Headaches in a Tertiary University Center. J Sex Med 2012; 9(3):761-769

 Nappi RE, Nappi G. Neuroendocrine aspects of migraine in women. Gynecol Endocrinol 2012; 28 Suppl 1(–):37-41

 De Carlo D, Toldo I, Dal Zotto L, Perissinotto E, Sartori S, Gatta M, Balottin U, Mazzotta G, Moscato D, Raieli V, Rossi LN, Sangermani R, Soriani S, Termine C, Tozzi E, Vecchio A, Zanchin G, Battistella PA. Osmophobia as an early marker of migraine: a follow-up study in juvenile patients. Cephalalgia 2012; 32(5):401-6

 Sarchielli P, Granella F, Prudenzano MP, Pini LA, Guidetti V, Bono G, Pinessi L, Alessandri M, Antonaci F, Fanciullacci M, Ferrari A, Guazzelli M, Nappi G, Sances G, Sandrini G, Savi L, Tassorelli C, Zanchin G. Italian guidelines for primary headaches: 2012 revised version. J Headache Pain 2012; 13 Suppl 2(–):31-70

 Allais G, Tullo V, Omboni S, Benedetto C, Sances G, Zava D, Ferrari MD, Bussone G. Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies. Neurol Sci 2012; 33 Suppl 1(–):65-9

 Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Fierro B, Brighina F. Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study. J Headache Pain 2012; 13(5):401-6

 Caverzasi E, Pichiecchio A, Poloni GU, Calligaro A, Pasin M, Palesi F, Castellazzi G, Pasquini M, Biondi M, Barale F, Bastianello S.Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature.Funct Neurol 2012; 27(1):13-22

 Moschiano F, Messina P, D’Amico D, Grazzi L, Frediani F, Casucci G, d’Onofrio F, Demurtas A, Beghi E, Bussone G. Headache, eating and sleeping behaviors and lifestyle factors in preadolescents and adolescents: preliminary results from an Italian population study. Neurol Sci 2012; 33 Suppl 1(–):87-90

 Bussone G, Usai S, Moschiano F. How to Investigate and Treat: Headache and Hyperprolactinemia. Curr Pain Headache Rep 2012; 16(4):365-70

 Tassorelli C, Greco R, Allena M, Terreno E, Nappi RE. Transdermal Hormonal Therapy in Perimenstrual Migraine: Why, When and How?Curr Pain Headache Rep 2012; 16(5):467-73

 Allena M, Cuzzoni MG, Tassorelli C, Nappi G, Antonaci F. An electronic diary on a palm device for headache monitoring: a preliminary experience. J Headache Pain 2012; 13(7):537-41

 Rossi P, Allena M, Tassorelli C, Sances G, Lorenzo CD, Faroni JV, Nappi G. Illicit drug use in cluster headache patients and in the general population: A comparative cross-sectional survey. Cephalalgia 2012; 32(14):1031-40

 Perrotta A, Arce-Leal N, Tassorelli C, Gasperi V, Sances G, Blandini F, Serrao M, Bolla M, Pierelli F, Nappi G, Maccarrone M, Sandrini G . Acute Reduction of Anandamide-Hydrolase (FAAH) Activity is Coupled With a Reduction of Nociceptive Pathways Facilitation in Medication-Overuse Headache Subjects After Withdrawal Treatment. Headache 2012; 52(9):1350-61

 Di Lorenzo C, Grieco GS, Santorelli FM. Migraine headache: a review of the molecular genetics of a common disorder. J Headache Pain 2012; 13(7):571-80

 Cosentino G, Alfonsi E, Lonati D, Locatelli CA, Valentino F, Brighina F. Positive ice pack test in a case of food-borne botulism: a clinical note. J Neurol 2012; 259(11):2486-7

 Piazza F, Chiappedi M, Maffioletti E, Galli F, Balottin U. Medication Overuse Headache in School-Aged Children: More Common Than Expected? Headache 2012; 52 (10): 1506–10

 Lorenzo CD, Coppola G, Currà A, Grieco G, Santorelli FM, Lepre C, Porretta E, Pascale E, Pierelli F. Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I/D genetic polymorphism.Cephalalgia 2012; 32(16):1189-97

 Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, Bisdorff A, Versino M, Evers S, Newman-Toker D. Vestibular migraine: diagnostic criteria. J vestibul res-equil 2012; 22(4): 167-72

 Serrao M, Ranavolo A, Andersen OK, Don R, Draicchio F, Conte C, Di Fabio R, Perrotta A, Bartolo M, Padua L, Santilli V, Sandrini G, Pierelli F. Reorganization of multi-muscle and joint withdrawal reflex during arm movements in post-stroke hemiparetic patients. Clin Neurophysiol 2012; 123(3):527-40

 Serrao M, Pierelli F, Ranavolo A, Draicchio F, Conte C, Don R, Di Fabio R, Lerose M, Padua L, Sandrini G, Casali C. Gait Pattern in Inherited Cerebellar Ataxias. Cerebellum 2012; 11(1):194-211

 Bartolo M, Zucchella C, Pace A, Lanzetta G, Vecchione C, Bartolo M, Grillea G, Serrao M, Tassorelli C, Sandrini G, Pierelli F. Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. J Neurooncol 2012; 107(3):537-44

 Conte C, Serrao M, Casali C, Ranavolo A, Silvia M, Draicchio F, Di Fabio R, Monami S, Padua L, Iavicoli S, Sandrini G, Pierelli F. Planned Gait Termination in Cerebellar Ataxias. Cerebellum 2012; 11:194–211

 Seidl Z, Vymazal J, Mechl M, Goyal M, Herman M, Colosimo C, Pasowicz M, Yeung R, Paraniak-Gieszczyk B, Yemen B, Anzalone N, Citterio A, Schneider G, Bastianello S, Ruscalleda J. Does Higher Gadolinium Concentration Play a Role in the Morphologic Assessment of Brain Tumors? Results of a Multicenter Intraindividual Crossover Comparison of Gadobutrol versus Gadobenate Dimeglumine (the MERIT Study). AJNR Am J Neuroradiol 2012; 33(6):1050-8

 Serrao M, Ranavolo A, Andersen OK, Conte C, Don R, Cortese F, Mari S, Draicchio F, Padua L, Sandrini G, Pierelli F. Adaptive behaviour of the spinal cord in the transition from quiet stance to walking. BMC Neurosci 2012; 13(1):80

 Ramat S, Colnaghi S, Boehler A, Astore S, Falco P, Mandalà M, Nuti D, Colagiorgio P, Versino M. A Device for the Functional Evaluation of the VOR in Clinical Settings. Front Neurol 2012; 3(–): 39

 Mari S, Serrao M, Casali C, Conte C, Ranavolo A, Padua L, Draicchio F, Iavicoli S, Monamì S, Sandrini G, Pierelli F . Turning strategies in patients with cerebellar ataxia. Exp Brain Res 2012; 222 (1-2): 65-75

 Smania N, Gandolfi M, Paolucci S, Iosa M, Ianes P, Recchia S, Giovanzana C, Molteni F, Avesani R, Di Paolo P, Zaccala M, Agostini M, Tassorelli C, Fiaschi A, Primon D, Ceravolo MG, Farina S. Reduced-Intensity Modified Constraint-Induced Movement Therapy Versus Conventional Therapy for Upper Extremity Rehabilitation After Stroke: A Multicenter Trial. Neurorehabil Neural Repair 2012; 26(9): 1035-45

 Alejaldre A, Díaz-Manera J, Ravaglia S, Tibaldi EC, D’Amore F, Morís G, Muelas N, Vílchez JJ, García-Medina A, Usón M, Martínez García FA, Illa I, Pichiecchio A. Trunk muscle involvement in late-onset Pompe disease: Study of thirty patients. Neuromuscul Disord 2012; 22 Suppl 2(–):S148-54

 Ravaglia S, De Filippi P, Pichiecchio A, Ponzio M, Saeidi Garaghani K, Poloni GU, Bini P, Danesino C. Can genes influencing muscle function affect the therapeutic response to enzyme replacement therapy (ERT) in late-onset Type II Glycogenosis? Mol Genet Metab 2012; 107(1-2):104-10

 Tormene P, Bartolo M, De Nunzio AM, Fecchio F, Quaglini S, Tassorelli C, Sandrini G. Estimation of human trunk movements by wearable strain sensors and improvement of sensor’s placement on intelligent biomedical clothes. Biomed Eng Online 2012; 11(–): 95

 Bartolo M, Zucchella C, Pace A, De Nunzio AM, Serrao M, Sandrini G, Pierelli F . Improving neuro-oncological patients care: basic and practical concepts for nurse specialist in neuro-rehabilitation. J Exp Clin Cancer Res 2012; 31(–):82

 Zamboni P, Menegatti E, Viselner G, Morovic S, Bastianello S. Fusion imaging technology of the intracranial veins. Phlebology 2012; 27(7):360-7

 Terzaghi M, Ratti PL, Manni F, Manni R. Sleep paralysis in narcolepsy: more than just a motor dissociative phenomenon? Neurol Sci 2012; 33(1):169-72

 Birbeck GL, French JA, Perucca E, Simpson DM, Fraimow H, George JM, Okulicz JF, Clifford DB, Hachad H, Levy RH. Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. Neurology 2012; 78(2):139-45

 Birbeck GL, French JA, Perucca E, Simpson DM, Fraimow H, George JM, Okulicz JF, Clifford DB, Hachad H. Levy For The Quality Standards Subcommittee Of The American Academy Of Neurology And The Ad Hoc Task Force Of The Commission On Therapeutic Strategies Of The International League Against Epilepsy RH. Antiepileptic drug selection for people with HIV/AIDS: Evidence-based guidelines from the ILAE and AAN. Epilepsia 2012; 53(1):207-14

 Moshé SL, Perucca E, Wiebe S, Mathern GW. The International League Against Epilepsy at the threshold of its second century: Year 2.Epilepsia 2012 ;53(1): 215-9

 Galanopoulou AS, Buckmaster PS, Staley KJ, Moshé SL, Perucca E, Engel J, Löscher W, Noebels JL, Pitkänen A, Stables J, White HS, O’Brien TJ, Simonato For The American Epilepsy Society Basic Science Committee And The International League Against Epilepsy Working Group On Recommendations For Preclinical Epilepsy Drug Discovery M. Identification of new epilepsy treatments: Issues in preclinical methodology. Epilepsia 2012; 53(3):571-582

 Veggiotti P, Pera MC, Teutonico F, Brazzo D, Balottin U, Tassinari CA. Therapy of encephalopathy with status epilepticus during sleep (ESES/CSWS syndrome): an update. Epileptic Disord 2012; 14(1):1-11

 Beghi E, Messina P, Pupillo E, Crichiutti G, Baglietto MG, Veggiotti P, Zamponi N, Casellato S, Margari L, Cianchetti C. Satisfaction with antiepileptic drugs in children and adolescents with newly diagnosed and chronic epilepsy. Epilepsy Res 2012; 100(1-2): 142-51

 D’Agostino A, Manni R, Limosani I, Terzaghi M, Cavallotti S, Scarone S. Challenging the myth of REM sleep behavior disorder: No evidence of heightened aggressiveness in dreams. Sleep Med 2012; 13(6):714-9

 Ratti PL, Terzaghi M, Minafra B, Repetto A, Pasotti C, Zangaglia R, Pacchetti C, Manni R. REM and NREM sleep enactment behaviors in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies. Sleep Med 2012; 13(7):926-32

 Postuma RB, Montplaisir JY, Pelletier A, Dauvilliers Y, Oertel W, Iranzo A, Ferini-Strambi L, Arnulf I, Hogl B, Manni R, Miyamoto T, Mayer G, Stiasny-Kolster K, Puligheddu M, Ju Y, Jennum P, Sonka K, Santamaria J, Fantini ML, Zucconi M, Leu-Semenescu S, Frauscher B, Terzaghi M, Miyamoto M, Unger MM, Cochen De Cock V, Wolfson C. Environmental risk factors for REM sleep behavior disorder: A multicenter case-control study. Neurology 2012; 79(5):428-34

 Brazzo D, Pera MC, Fasce M, Papalia G, Balottin U, Veggiotti P. Epileptic Encephalopathies with Status Epilepticus during Sleep: New Techniques for Understanding Pathophysiology and Therapeutic Options. Epilepsy Res Treat 2012; (–): 642725

 Terzaghi M, Sartori I, Tassi L, Rustioni V, Proserpio P, Lorusso G, Manni R, Nobili L. Dissociated local arousal states underlying essential clinical features of non-rapid eye movement arousal parasomnia: an intracerebral stereo-electroencephalographic study. J Sleep Res 2012; 21(5):502-6

 Perucca E. What clinical trial designs have been used to test antiepileptic drugs and do we need to change them? Epileptic Disord 2012; 14(2):124-31

 Russo E, Scicchitano F, Citraro R, Aiello R, Camastra C, Mainardi P, Chimirri S, Perucca E, Donato G, De Sarro G. Protective activity -lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models epileptogenesis. Neuroscience 2012; 226C(–):282-8

 Arida RM, Scorza FA, Cavalheiro EA, Perucca E, Moshé SL. Can people with epilepsy enjoy sports? Epilepsy Res 2012; 98, 94-5

 Baulac M, De Boer H, Elger C, Glynn M, Kälviäinen R, Little A, Mifsud J, Perucca E, Pitkänen A. The Written Declaration on Epilepsy: An important achievement for Europe and beyond. Seizure 2012; 21(1): 75-6

 Gana S, Veggiotti P, Sciacca G, Fedeli C, Bersano A, Micieli G, Maghnie M, Ciccone R, Rossi E, Plunkett K, Bi W, Sutton VR, Zuffardi O, Dimauro S, Hirano M, Santos-Ocaña C, Navas P.19q13.11 cryptic deletion: description of two new cases and indication for a role of WTIP haploinsufficiency in hypospadias. Eur J Hum Genet 2012; 20(8):852-6

 Salviati L, Trevisson E, Rodriguez Hernandez MA, Casarin A, Pertegato V, Doimo M, Cassina M, Agosto C, Desbats MA, Sartori G, Sacconi S, Memo L, Zuffardi O, Artuch R, Quinzii C. Haploinsufficiency of COQ4 causes coenzyme Q10 deficiency. J Med Genet 2012; 49(3):187-91

 Vetro A, Bouman K, Hastings R, McMullan DJ, Vermeesch JR, Miller K, Sikkema-Raddatz B, Ledbetter DH, Zuffardi O, van Ravenswaaij-Arts CM . The introduction of arrays in prenatal diagnosis: A special challenge. Hum Mutat 2012; 33(6):923-9

 Cellini E, Disciglio V, Novara F, Barkovich JA, Mencarelli MA, Hayek J, Renieri A, Zuffardi O, Guerrini R. Periventricular heterotopia with white matter abnormalities associated with 6p25 deletion. Am J Med Genet A 2012;158A(7): 1793-7

 Rossi E, Giorda R, Bonaglia MC, Candia SD, Grechi E, Franzese A, Soli F, Rivieri F, Patricelli MG, Saccilotto D, Bonfante A, Giglio S, Beri S, Rocchi M, Zuffardi O. De Novo Unbalanced Translocations in Prader-Willi and Angelman Syndrome Might Be the Reciprocal Product of inv dup(15)s. PLoS One. 2012; 7(6):e39180

 Di Lorenzo C, Di Lorenzo G, Daverio A, Pasqualetti P, Coppola G, Giannoudas I, Barone Y, Grieco GS, Niolu C, Pascale E, Santorelli FM, Nicoletti F, Pierelli F, Siracusano A, Seri S. The Val66Met Polymorphism of the BDNF Gene Influences Trigeminal Pain-Related Evoked Responses. J Pain 2012; 13(9):866-73

 Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA, Jenkinson EM, Bacino CA, Battini R, Bertini E, Brogan PA, Brueton LA, Carpanelli M, De Laet C, de Lonlay P, Del Toro M, Desguerre I, Fazzi E, Garcia-Cazorla A, Heiberg A, Kawaguchi M, Kumar R, Lin JP, Lourenco CM, Male AM, Marques W Jr, Mignot C, Olivieri I, Orcesi S, Prabhakar P, Rasmussen M, Robinson RA, Rozenberg F, Schmidt JL, Steindl K, Tan TY, van der Merwe WG, Vanderver A, Vassallo G, Wakeling EL, Wassmer E, Whittaker E, Livingston JH, Lebon P, Suzuki T, McLaughlin PJ, Keegan LP, O’Connell MA, Lovell SC, Crow YJ. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet 2012; 44(11):1243-8

 Van Houdt JK, Nowakowska BA, Sousa SB, van Schaik BD, Seuntjens E, Avonce N, Sifrim A, Abdul-Rahman OA, van den Boogaard MJ, Bottani A, Castori M, Cormier-Daire V, Deardorff MA, Filges I, Fryer A, Fryns JP, Gana S, Garavelli L, Gillessen-Kaesbach G, Hall BD, Horn D, Huylebroeck D, Klapecki J, Krajewska-Walasek M, Kuechler A, Lines MA, Maas S, Macdermot KD, McKee S, Magee A, de Man SA, Moreau Y, Morice-Picard F, Obersztyn E, Pilch J, Rosser E, Shannon N, Stolte-Dijkstra I, Van Dijck P, Vilain C, Vogels A, Wakeling E, Wieczorek D, Wilson L, Zuffardi O, van Kampen AH, Devriendt K, Hennekam R. Vermeesch JR Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome. Nat Genet 2012; 44(4):445-9, S1